IRIS

1.1 Articolo in rivista: [35988] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 4.161 a 4.180 di 35.988
Titolo Data di pubblicazione Autore(i) File
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis 1-gen-2020 Schettini, F; Pascual, T; Conte, B; Chic, N; BRASÓ-MARISTANY, F; Galván, P; Martínez, O; Adamo, B; Vidal, M; Muñoz, M; FERNÁNDEZ-MARTINEZ, A; Rognoni, C; Griguolo, G; Guarneri, V; Conte, Pf; Locci, M; Brase, Jc; GONZALEZ-FARRE, B; Villagrasa, P; DE PLACIDO, S; Schiff, R; Veeraraghavan, J; Rimawi, Mf; Osborne, Ck; Pernas, S; Perou, Cm; Carey, La; Prat, A
Management of young women with early breast cancer 1-gen-2018 Poggio, F; Lambertini, M; Bighin, C; Conte, B; Blondeaux, E; D'Alonzo, A; Dellepiane, C; Boccardo, F; DEL MASTRO, L
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer 1-gen-2021 Schettini, F; Chic, N; BRASÓ-MARISTANY, F; Paré, L; Pascual, T; Conte, B; MARTÍNEZ-SÁEZ, O; Adamo, B; Vidal, M; Barnadas, E; FERNÁNDEZ-MARTÍNEZ, A; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Cejalvo, Jm; Perrone, G; Sabarese, G; Zalfa, F; Peg, V; Fasani, R; Villagrasa, P; Gavilá, J; Barrios, Ch; Lluch, A; Martín, M; Locci, M; DE PLACIDO, S; Prat, A
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 1-gen-2020 Blondeaux, Eva; Lambertini, Matteo; Michelotti, Andrea; Conte, Benedetta; Benasso, Marco; Dellepiane, Chiara; Bighin, Claudia; Pastorino, Simona; Levaggi, Alessia; D’ Alonzo, Alessia; Poggio, Francesca; Buzzatti, Giulia; Molinelli, Chiara; Fregatti, Piero; Bertoglio, Sergio; Boccardo, Francesco; Del Mastro, Lucia
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 1-gen-2020 Tagliamento, M; Spagnolo, F; Poggio, F; Soldato, D; Conte, B; Ruelle, T; Barisione, E; DE MARIA, A; DEL MASTRO, L; DI MAIO, M; Lambertini, M
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence 1-gen-2022 Conte, B.; Soldato, D.; Razeti, M. G.; Fregatti, P.; de Azambuja, E.; Schettini, F.; Prat, A.; Del Mastro, L.; Lambertini, M.
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials 1-gen-2023 Conte, Benedetta; Boni, Luca; Bisagni, Giancarlo; Durando, Antonio; Sanna, Giovanni; Gori, Stefania; Garrone, Ornella; Tamberi, Stefano; De Placido, Sabino; Schettini, Francesco; Pazzola, Antonio; Ponzone, Riccardo; Montemurro, Filippo; Lunardi, Gianluigi; Notaro, Rosario; De Angioletti, Maria; Turletti, Anna; Mansutti, Mauro; Puglisi, Fabio; Frassoldati, Antonio; Porpiglia, Mauro; Fabi, Alessandra; Generali, Daniele; Scognamiglio, Giovanni; Rossi, Maura; Brasó Maristany, Fara; Prat, Aleix; Cardinali, Barbara; Piccioli, Patrizia; Serra, Martina; Lastraioli, Sonia; Bighin, Claudia; Poggio, Francesca; Lambertini, Matteo; Del Mastro, Lucia
Luteinizing hormone-releasing hormone analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor-positive breast cancer 1-gen-2017 Conte, B; Poggio, F; DEL MASTRO, L
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial 1-gen-2020 Lambertini, Matteo; Poggio, Francesca; Bruzzone, Marco; Conte, Benedetta; Bighin, Claudia; de Azambuja, Evandro; Giuliano, Mario; De Laurentiis, Michele; Cognetti, Francesco; Fabi, Alessandra; Bisagni, Giancarlo; Durando, Antonio; Turletti, Anna; Urracci, Ylenia; Garrone, Ornella; Puglisi, Fabio; Montemurro, Filippo; Ceppi, Marcello; Del Mastro, Lucia
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy 1-gen-2021 MARTÍNEZ-SÁEZ, O; Pascual, T; BRASÓ-MARISTANY, F; Chic, N; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Schettini, F; Conte, B; Vidal, M; Adamo, B; Martínez, A; Muñoz, M; Moreno, R; Villagrasa, P; Salvador, F; Ciruelos, Em; Faull, I; Odegaard, Ji; Prat, A
Frequency and spectrum of PIK3CA somatic mutations in breast cancer 1-gen-2020 MARTÍNEZ-SÁEZ, O; Chic, N; Pascual, T; Adamo, B; Vidal, M; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Schettini, F; Conte, B; BRASÓ-MARISTANY, F; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Martinez, A; Muñoz, M; Prat, A
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 1-gen-2019 Conte, Benedetta; Fabi, Alessandra; Poggio, Francesca; Blondeaux, Eva; Dellepiane, Chiara; D'Alonzo, Alessia; Buono, Giuseppe; Arpino, Grazia; Magri, Valentina; Naso, Giuseppe; Presti, Daniele; Mura, Silvia; Fontana, Andrea; Cognetti, Francesco; Molinelli, Chiara; Pastorino, Simona; Bighin, Claudia; Miglietta, Loredana; Boccardo, Francesco; Lambertini, Matteo; Del Mastro, Lucia
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 1-gen-2023 Conte, B; Montemurro, F; Levaggi, A; Blondeaux, E; Molinelli, C; Cardinali, B; Poggio, F; Buzzatti, G; Bighin, C; Lambertini, M; DEL MASTRO, L
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 1-gen-2018 Poggio, F; Bruzzone, M; Ceppim, ; Conte, B; Martel, S; Maurer, C; Tagliamento, M; Viglietti, G; DEL MASTRO, L; DE AZAMBUJA, E; Lambertini, M
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 1-gen-2023 BRASÓ-MARISTANY, F; Griguolo, G; Chic, N; Pascual, T; Paré, L; Maues, J; Galván, P; Dieci, Mv; Miglietta, F; Giarratano, T; MARTÍNEZ-SÁEZ, O; MARÍN-AGUILERA, M; Schettini, F; Conte, B; Angelats, L; Vidal, M; Adamo, B; Muñoz, M; Sanfeliu, E; González, B; Vivancos, A; Villagrasa, P; Parker, Js; Perou, Cm; Conte, P; Prat, A; Guarneri, V
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer 1-gen-2022 Prat, A; Guarneri, V; Pascual, T; BRASÓ-MARISTANY, F; Sanfeliu, E; Paré, L; Schettini, F; Martínez, D; Jares, P; Griguolo, G; Dieci, Mv; Cortés, J; LLOMBART-CUSSAC, A; Conte, B; MARÍN-AGUILERA, M; Chic, N; PUIG-BUTILLÉ, Ja; Martínez, A; Galván, P; Tsai, Yh; GONZÁLEZ-FARRÉ, B; Mira, A; Vivancos, A; Villagrasa, P; Parker, Js; Conte, P; Perou, Cm
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 1-gen-2020 Prat, A; Guarneri, V; Paré, L; Griguolo, G; Pascual, T; Dieci, Mv; Chic, N; BRASÓ-MARISTANY, F; Vidal, M; Conte, B; Oliveira, M; Saura, C; Pernas, S; Alarcón, J; LLOMBART-CUSSAC, A; Cortés, J; Manso, L; López, R; Ciruelos, E; Schettini, F; Villagrasa, P; Carey, La; Perou, Cm; Piacentini, F; D'Amico, R; Tagliafico, E; Parker, Js; Conte, P
Update on the management of breast cancer during pregnancy 1-gen-2020 Poggio, F.; Tagliamento, M.; Pirrone, C.; Soldato, D.; Conte, B.; Molinelli, C.; Cosso, M.; Fregatti, P.; Del Mastro, L.; Lambertini, M.
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 1-gen-2021 Conte, B; Schettini, F; Buono, G; DE PLACIDO, P; Parola, S; Griguolo, G; Fabi, A; Bighin, C; Riccardi, F; Cianniello, D; DE LAURENTIIS, M; Puglisi, F; Pelizzari, G; Bonotto, M; Russo, S; Frassoldati, A; Pazzola, A; Montemurro, F; Lambertini, M; Guarneri, V; Cognetti, F; Locci, M; Generalli, D; Conte, P; DE PLACIDO, S; Giuliano, M; Arpino, G; DEL MASTRO, L
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 1-gen-2018 Poggio, Francesca; Bruzzone, Marco; Ceppi, Marcello; Conte, Benedetta; Martel, Samuel; Maurer, Christian; Tagliamento, Marco; Viglietti, Giulia; Del Mastro, Lucia; de Azambuja, Evandro; Lambertini, Matteo
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 4.161 a 4.180 di 35.988
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista35987
  • 4 Contributo in Atti di Convegno ...1
Autore
  • ARNEODO, Michele1426
  • ARCIDIACONO, Roberta1411
  • RUSPA, Marta1323
  • GAIDANO, Gianluca764
  • RAMELLO, Luciano682
  • SITTA, Mario630
  • CORTESE, Pietro622
  • SACERDOTE, Carlotta545
  • Patti, Giuseppe Rocco Salvatore425
  • PIRISI, Mario410
Data di pubblicazione
  • In corso di stampa66
  • 2020 - 20269725
  • 2010 - 201913040
  • 2000 - 20097282
  • 1990 - 19994152
  • 1980 - 19891467
  • 1970 - 1979232
  • 1962 - 196924
Rivista
  • PHYSICS LETTERS. SECTION B771
  • JOURNAL OF HIGH ENERGY PHYSICS498
  • PHYSICAL REVIEW LETTERS295
  • THE EUROPEAN PHYSICAL JOURNAL. C,...284
  • PHYSICAL REVIEW D234
  • JOURNAL OF HIGH ENERGY PHYSICS183
  • PLOS ONE181
  • BLOOD169
  • INTERNATIONAL JOURNAL OF MOLECULA...163
  • NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
  • Humans1437
  • Female757
  • Male607
  • Middle Aged459
  • Adult415
  • Aged406
  • COVID-19343
  • Italy297
  • Animals217
  • Treatment Outcome196
Lingua
  • eng24616
  • ita5280
  • fre259
  • spa169
  • ger57
  • rus29
  • und26
  • por17
  • lat15
  • grc6
Accesso al fulltext
  • no fulltext21340
  • reserved7309
  • open4916
  • restricted2307
  • partially open90
  • embargoed17
  • mixed9